Development and Validation of a New RP-UFLC Method for the Assay of Binary Mixture of Perindopril Erbumine and Amlodipine Besylate

Main Article Content

Mukthinuthalapati Mathrusri Annapurna

Abstract

Introduction: Perindopril erbumine is a drug used for the treatment of hypertension which acts by inhibition of angiotensin-converting enzyme. Amlodipine besylate is a calcium channel blocker. A new reversed-phase ultra-fast liquid chromatography method has been developed for the simultaneous determination of perindopril erbumine and amlodipine besylate. Materials and Methods: An ion pairing agent, tetra butyl ammonium hydrogen sulfate (10 mM) with acetonitrile was used as mobile phase (pH to 3.45) (45:55, v/v) on isocratic mode with flow rate 0.8 mL/min (Detection wavelength 215 nm). Results and Discussion: Beer-Lambert’s law was obeyed over the concentration range 0.1–20 μg/mL and 0.25–50 μg/mL with linear regression equation y = 28559x – 1188 (R² = 0.9999) and y = 20401x + 7.07 (R² = 0.9999) for perindopril erbumine and amlodipine besylate, respectively. The limit of quantification values were found to be 0.0912 μg/mL and 0.2123 μg/mL and that of limit of detection values was 0.0291 μg/mL and 0.0691 μg/mL for perindopril erbumine and amlodipine besylate, respectively. The proposed method was validated and found to be simple, precise, accurate, robust, and useful for the routine analysis of pharmaceutical formulations. Conclusion: The proposed method was validated and found to be simple, precise, accurate, robust, and useful for the routine analysis of pharmaceutical formulations.

Downloads

Download data is not yet available.

Article Details

How to Cite
Annapurna, M. M. . (2022). Development and Validation of a New RP-UFLC Method for the Assay of Binary Mixture of Perindopril Erbumine and Amlodipine Besylate. Asian Journal of Pharmaceutics (AJP), 16(4). https://doi.org/10.22377/ajp.v16i4.4609
Section
ORIGINAL ARTICLES

Most read articles by the same author(s)